• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Out-of-Pocket Healthcare Expenditures in the United States: Forecasts to 2019

$499.00 – $1,000.00

Clear
SKU: KLI5558864 Categories: Healthcare Market Research, Insurance & Managed Care Pages: 70
  • Description
  • Table of Contents
  • Latest reports

Description

The Out-of-Pocket Healthcare Expenditures in the United States

Out-of-pocket expenditures for health care products and services in the United States continue to rise and in 2015 represent a significant portion of consumers’ incomes. This is the result of a variety of factors including an aging U.S. population, rising utilization of medical products and services, and ongoing cutbacks to both public (federal and state) and private health coverage. Over the years, U.S. consumers’ annual out-of-pocket health care costs have risen from about $250 per person in 1980 to $1,300 in 2015, with yearly increases of about $40 to $50. Increases for health plan premiums, in particular, have outpaced increases in overall prices and workers’ earnings.

This Kalorama Information report, Out-of-Pocket Spending n the United States, details the trend of consumers purchasing their healthcare with their own cash or credit cards and/or various financing programs. Included in this report’s analysis is the following:

  • Total Spending By Consumers
  • Proportion That is Cash, Credit Card, HSA and Other Programs
  • Co-Pay Spending, 2009-2014 and Projected to 2019
  • Premium Spending, 2009-2014 and Projected to 2019
  • Direct Healthcare Purchases, 2009-2014 and Projected to 2019
  • Elective Spending
  • Non-Elective Spending

Direct payments represent payments made from consumers directly to health care providers without reimbursement by insurers. For the uninsured and many underinsured, such payments represent the primary means of funding health care. For those with health care insurance, direct payments supplement plan payments. Initially, direct payments will be made to meet deductible levels; after that, direct payments may be required to meet plan co-payments in the case of plans that do not fund 100% of expenses after deductibles are met. This is the case for a growing number of plans that pay 80% to 90% of expenses after deductibles. Furthermore, many plans also set limits on payments for certain products or services, so that participants must self-fund further expenditures after those limits are met. Thus, direct payments may be made by both uninsured and insured persons. For both groups, however, the size of direct payments for health care continues to rise.

Health care premiums represent fees paid by plan participants to maintain membership in the plan. Unlike co-payments and deductibles, they are not tied directly to receipt of products or services. As the single most important way that health care plans are financed, premiums continue to rise as MCOs attempt to offset their own increasing expenses. In 2013, the most recent year for which data is available, HMO premiums rose by more than 10%, according to Hewitt Associates. Much of this growth is attributed to healthcare price increases in excess of inflation (such as through the utilization of higher-priced technologies) and about one quarter is the result of increased utilization.

Co-payments may be set either at a fixed rate or as a proportion of the cost of each covered product or service. Over the past two decades, co-pays have been rising as MCOs continue to utilize them as a means to both help offset payments to providers and encourage/discourage certain consumer behaviors. For example, co-payments are often set higher on more expensive alternatives (new and/or brand name medicines, utilization of out-of-network providers, innovative procedures, etc.) and lower on less expensive choices (generic and/or lower cost medicines, etc.).

Consumers in the United States utilize a variety of methods to pay for health care products and services. These are required in instances when payment is not made directly from a health care plan directly to the provider. The key payment methods utilized are:

  • cash or check;
  • credit cards;
  • loans and lines of credit;
  • flexible spending accounts;
  • health savings accounts;
  • medical financing.

Consumers from all socioeconomic groups are facing high out-of-pocket expenditures for health care. However, certain groups are more vulnerable to this threat and represent a larger proportion of total such spending. These include:

  • the uninsured and underinsured;
  • Medicaid recipients;
  • disabled persons;
  • senior citizens;
  • the mentally ill;
  • obese persons;
  • persons with chronic medical conditions.

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

Out-of-Pocket Spending

CHAPTER TWO: INTRODUCTION

Types of Expenditures

Insurance Co-Payments

Direct Payments

Premiums and Plan Fees

Payment Methods

Cash or Check

Credit Cards

Loans and Lines of Credit

Flexible Spending Accounts

Health Savings Accounts

Medical Financing

Amount Financed

Elective Procedures

Non-Elective Procedures and Prescription Drugs

Non-Elective Procedures and Prescription Drugs

Consumers Who Pay Out-of-pocket

The Uninsured and Underinsured

Medicaid Recipients

Persons with Chronic Conditions

Trends

Out-of-pocket Expenditure Growth Drivers

Out-of-pocket Expenditure Growth Constraints

CHAPTER THREE: MARKET ANALYSIS

Forecasts

Expenditures by Type

Payment Methods

Amount Financed

Types of Expenses Financed

Consumers Who Pay Out of Pocket

LIST OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

Figure 1-1

Out-of-Pocket Spending on Healthcare in the United States (billions)

CHAPTER TWO: INTRODUCTION

Figure 2-1

Premium Increases vs. Increases in Workers Earnings and Prices, 2000 – 2014

Figure 2-2

Consumer Out-of-pocket Health Care Expenditures, 2014(Co-pays, Direct Payments, Premiums)

Figure 2-3

Consumer Out-of-pocket Health Care Expenditures by Payment Type, 2014 (HSAs, Health Care Financing Programs, Loans or Lines of Credit, FSAs, Credit Cards, Cash or Check )

Table 2-1

Main Business Activities of Selected Medical Financing Companies, 2014 (Financing Elective Procedures, Financing Non-Elective Procedures, Non-Medical Consumer Credit)

Figure 2-4

Average Out-of-pocket Payment by U.S. Residents with Health Care Spending by Percentile of Total Health Spending, 2014 (Cosmetic Surgery, Cosmetic Dentistry, Eye Procedures,

Chiropractic Services, Hair Restoration, Fertility Treatments, Weight Loss , Other)

Figure 2-5

Methods of Financing Elective Procedures, 2014 (Loans or Lines of Credit, Cash or Check, Health Care Financing Programs, Credit Cards)

Figure 2-6

Average Share Paid Out-of-pocket by U.S. Residents with Health Care Spending by Type of Service, 2014 (Hospital, Outpatient, Office Based Visit, Prescription Drugs, Emergency

Room, Dental, Home Health, Vision, Other Health Care)

Figure 2-7

Average Share Paid Out-of-pocket by U.S. Residents with Health Care Spending by Percentile of Total Health Spending and Type of Service, 2014 (Hospital, Outpatient, Office Based Visit, Prescription Drugs, Emergency Room, Dental, Home Health, Vision, Other Health Care) 26

Figure 2-8

Distribution of Out-of-pocket Spending on Non-Elective Procedures for the Average Person, 2014 (Prescription Drugs, Emergency Room, Dental, Vision, Other Health Care, Hospital, Outpatient, Office Based Visit)

Figure 2-9

Distribution of Out-of-pocket Spending for the Average Person, by Spending Level, 2014(Hospital, Outpatient, Office Based Visit, Prescription Drugs, Emergency Room, Dental,Home Health, Vision, Other Health Care)

Figure 2-10

Drug Cost Coverage by Payor Type (Public, Private, Cash):1965, 1986, 2000, 2005, 2010, 2015

Table 2-2

Obesity in the United States, 1980 – 2019

Figure 2-11

Coverage of Adults under Age 65 with Chronic Conditions, 2014 (Privately Insured, Medicare orMedicaid, Uninsured, Other)

CHAPTER THREE: MARKET ANALYSIS – OUT-OF-POCKET SPENDING IN THE US, 2014— 2019

Table 3-1

Selected Rx-to-OTC Switches in the United States, 1990 – 2014

Table 3-2

Consumer Out-of-pocket Expenditures per Worker, 2009–2019

Table 3-3

Consumer Out-of-pocket Expenditures by Type, 2009–2019

Figure 3-1

Proportion of Consumer Out-of-pocket Spending by Type of Health Care Expenditure, 2009, 2014, 2019 (Direct Payments, Co-pays, Premiums)

Table 3-4

Consumer Out-of-pocket Expenditures by Type, 2009–2019

Figure 3-2

Proportion of Consumer Out-of-Pocket Spending by Payment Type, 2009, 2014, 2019 (Credit Cards, FSAs, Health Care Financing Programs, Cash or Check, Loans or Lines of Credit, HSAs)

Table 3-5

Amount of Consumer Out-of-Pocket Expenditures for Elective Procedures That Are Financed, 2009–2019

Table 3-6

Amount of Consumer Out-of-Pocket Expenditures for Non-Elective Procedures That Are Financed, 2009–2019

Figure 3-3

Proportio of Consumer Out of Pocket Spending for Elective Procedures (Cosmetic Surgery,

Consmetic Dentistry, Eye Procedures, Chiropractic Services, Hair Restoration, Fertility Treatment, Weight Loss Surgery)

Figure 3-4:

Distribution of Out-of-Pocket Spending on Non-Elective Procedures for the Average Person, 2014, 2019 (Hospital, Outpatient, Office Based Visit, Prescription Drugs, Emergency Room, Dental, Vision, Other Health Care)

Figure 3-5

Proportion of Consumer Out-of-Pocket Spending for Non-Elective Procedures That is Financed(All Methods), 2014 – 2019 (Hospital, Outpatient, Office Based Visit, Prescription Drugs,Emergency Room, Dental, Home Health, Vision)

Table 3-7

Size of High Risk Groups for High Out-of-Pocket Health Care Expenditures, 2009–2019(Uninsured and Underinsured, Medicaid Recipients, The Disabled, Senior Citizens, The Mentally Ill, The Obese, Persons with Chronic Conditions)

 

    Molecular Diagnostics in Oncology, Genetic/Inherited Diseases, and NIPT, 2023-2028
    November 29, 2023
    Remote Patient Monitoring and Telehealth Markets, 13th Edition
    November 27, 2023
    World Market for Laboratory Information Systems (LIS): Software, Hardware, and Implementation for Clinical Labs, 2022-2027
    October 18, 2023
    Out-of-Pocket Spending in Healthcare (Pharmaceuticals, Surgeries, Tests, Electives, Premiums, Copays, Doctor Visits, Other), 6th Edition
    July 13, 2023

Related products

  • Placeholder image

    World Veterinary Health Products (Animal Pharmaceuticals, Vaccines, OTC and Performance Enhancers)

    $995.00 – $7,000.00
  • Placeholder image

    Obesity, Weight Loss and Diet Management Markets (Pharmaceutical, Surgical and Dietary Approaches)

    $995.00 – $4,200.00
  • Placeholder image

    RFID Opportunities in Healthcare in the U.S.

    $1,995.00 – $7,990.00
  • Placeholder image

    Organ Transplant Immunosuppressive Markets

    $995.00 – $1,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Proteomics Research Markets: Instruments & Consumables (Mass Spectrometry,...Cell Culture: The Market for Media, Sera and Reagents
Scroll to top